Automated Immunoassay Analyzers Market Report 2026

Automated Immunoassay Analyzers Market Overview

• Automated Immunoassay Analyzers market size has reached to $23.09 billion in 2025 • Expected to grow to $44.93 billion in 2030 at a compound annual growth rate (CAGR) of 14.2% • Growth Driver: Rising Number Of Hospitals Fueling Demand For Automated Immunoassay Analyzers • Market Trend: Advancements In Automated Immunoassay Analyzer Enhances Diagnostic Efficiency • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Automated Immunoassay Analyzers Market?

Automated immunoassay analyzers refer to advanced laboratory instruments designed to perform immunoassays with minimal human intervention. These analyzers utilize automated processes to detect and measure specific proteins, hormones, and other substances in biological samples, improving accuracy and efficiency in diagnostic testing. They are widely used in clinical laboratories for disease diagnosis, monitoring, and research applications. The main types of products in the automated immunoassay analyzers are immunofluorescence, chemiluminescence, enzyme-linked fluorescent system (ELISA), multiplexed assay system, and radioimmunoassay. Immunofluorescence refers to a technique that uses fluorescent-labeled antibodies to detect specific antigens in biological samples. The various applications involve infectious diseases, endocrinology, drug monitoring, cardiology, oncology, allergy testing, and others and are used by different end-users such as hospitals, diagnostic laboratories, research and academic laboratories, pharmaceutical and biotechnology companies, and others.

What Is The Automated Immunoassay Analyzers Market Growth Forecast?

The automated immunoassay analyzers market size is expected to see rapid growth in the next few years. It will grow to $44.93 billion in 2030 at a compound annual growth rate (CAGR) of 14.2%. The growth in the forecast period can be attributed to rising chronic and endocrine disorder testing needs, growing oncology and biomarker testing, demand for faster turnaround diagnostic results, increasing integration of automated platforms in research labs, expansion of pharmaceutical and biotech r&d testing applications. Major trends in the forecast period include growing demand for high-throughput diagnostic testing, increased adoption in infectious disease and endocrinology testing, expansion of automated testing in research and academic laboratories, rising utilization in therapeutic drug monitoring and oncology diagnostics, standardization of laboratory workflows to improve testing efficiency.

Global Automated Immunoassay Analyzers Market Segmentation

1) By Product: Immunofluorescence, Chemiluminescence, Enzyme Linked Fluorescent System (ELISA), Multiplexed Assay System, Radioimmunoassay 2) By Application: Infectious Diseases, Endocrinology, Drug Monitoring, Cardiology, Oncology, Allergy Testing, Other Applications 3) By End-User: Hospitals, Diagnostic Laboratories, Research And Academic Laboratories, Pharmaceutical And Biotechnology Companies, Other End-Users Subsegments: 1) By Immunofluorescence: Fluorescent Labeling Kits, Fluorescent Detectors And Readers, Immunofluorescence Reagents 2) By Chemiluminescence: Chemiluminescent Labels And Reagents, Chemiluminescence Detectors And Readers, Chemiluminescent Assay Kits 3) By Enzyme Linked Fluorescent System (ELISA): ELISA Kits (Capture And Detection Kits), ELISA Microplates And Plates Coating Systems, Enzyme Substrates And Detection Reagents 4) By Multiplexed Assay System: Multiplexed Assay Kits, Multi-Analyte Detection Systems, Multiplexing Software And Data Analysis Tools 5) By Radioimmunoassay (RIA): Radioactive Isotope Kits, Gamma Counters, Radiolabeled Reagents

What Is The Driver Of The Automated Immunoassay Analyzers Market?

The increasing number of hospitals is expected to propel the growth of the automated immunoassay analyzers market going forward. Hospitals refer to healthcare institutions that provide medical, surgical, and diagnostic services to patients requiring treatment or emergency care. They function as organized facilities staffed by healthcare professionals to deliver inpatient and outpatient care across various specialties. The number of hospitals is rising due to increasing healthcare demands from a growing and aging population. Automated immunoassay analyzers enhance efficiency and accuracy in hospitals by rapidly processing large volumes of diagnostic tests for various diseases and conditions. For instance, in May 2023, according to the American Health Care Association, a US-based nonprofit organization, in 2023, the number of hospitals in the US increased to 6,129 from 6,093 in 2022, showing an increase of 0.59%. Therefore, the increasing number of hospitals is driving the growth of the automated immunoassay analyzers industry.

Key Players In The Global Automated Immunoassay Analyzers Market

Major companies operating in the automated immunoassay analyzers market are Roche Diagnostics AG, Abbott Laboratories, Danaher Corporation, Siemens Healthineers, Becton Dickinson and Company, Tosoh Corporation, bioMérieux SA, QuidelOrtho Corporation, Sysmex Corporation, Bio-Rad Laboratories Inc, Qiagen NV, Werfen Group SA, DiaSorin SpA, Bio-Techne Corporation, Meril Life Sciences Private Limited, Randox Laboratories Ltd, Getein Biotech Inc, Aesku Diagnostics GmbH & Co KG, Carolina Liquid Chemistries Corporation, Chengdu Seamaty Technology Co Ltd, Hipro Biotechnology Co Ltd

Global Automated Immunoassay Analyzers Market Trends and Insights

Major companies operating in the automated immunoassay analyzers market are focusing on developing innovative products, such as compact immunoassay analyzers, to gain a competitive advantage. Compact immunoassay analyzers are smaller, portable devices designed for conducting immunoassay tests that detect specific biomarkers in biological samples. They offer convenience and efficiency in various healthcare settings, particularly where space and mobility are limited. For instance, in July 2023, Siemens Healthineers, a Germany-based healthcare company, launched the Atellica CI Analyzer, a compact laboratory testing system aimed at improving efficiency in both immunoassay and clinical chemistry testing. By combining these two testing methods into a single platform, the Atellica CI Analyzer meets the growing demand for versatile systems capable of conducting various tests efficiently. The features of this product align well with current market trends, effectively addressing the challenges laboratories face in delivering timely and accurate diagnostic results. Random access sampling, micro-volume aspiration, and automated maintenance and quality control scheduling assist laboratories in achieving more consistent and predictable sample processing times.

What Are Latest Mergers And Acquisitions In The Automated Immunoassay Analyzers Market?

In July 2024, Roche, a Switzerland-based provider of diagnostics, pharmaceutical products, and point-of-care testing solutions, acquired LumiraDx’s Point of Care technology for an undisclosed amount. With this acquisition, Roche sought to complement and decentralize its diagnostics offering by adding a multi-assay point-of-care platform that consolidates immunoassay and clinical chemistry testing—supporting Roche’s strategic objective to expand access to rapid, near-patient testing in primary care and low-resource settings. LumiraDx is a UK-based developer of a multi-assay point-of-care platform that performs immunoassay and clinical chemistry tests on a single instrument.

Regional Outlook

North America was the largest region in the automated immunoassay analyzer market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Automated Immunoassay Analyzers Market?

The automated immunoassay analyzers market consists of sales of sample handlers, reagents, incubation chambers, thermal printers, and wash stations. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.